Increased immunoglobulin response to gamma-interferon by lymphocytes from patients with systemic lupus erythematosus

Clin Immunol Immunopathol. 1988 Jan;46(1):129-40. doi: 10.1016/0090-1229(88)90013-x.

Abstract

The factors responsible for abnormal B-cell activation in systemic lupus erythematosus (SLE) are incompletely understood. This study tested the hypothesis that the abnormal B-cell activation observed in human SLE may be due to an augmented response to a helper signal. We demonstrated that non-T cells from 10 of 19 SLE patients increased IgG production in response to interferon-gamma (IFN-gamma) by a mean factor of 20.9 +/- 3.9 over resting levels, while controls stimulated a mean factor of 3.0 +/- 0.5 (P less than 0.005). We found no relationship of IFN-gamma responsiveness to disease activity. Serotyping for HLA A, B, C, and D loci suggested that the hyperresponsiveness may be genetically linked to HLA-Cw7. We conclude that IFN-gamma may contribute to the development and perpetuation of SLE in a subset of patients with SLE.

MeSH terms

  • Antibody Formation / drug effects*
  • B-Lymphocytes / immunology*
  • HLA Antigens / analysis
  • HLA-C Antigens*
  • Humans
  • Interferon-gamma / pharmacology*
  • Lupus Erythematosus, Systemic / immunology*
  • Lupus Erythematosus, Systemic / pathology
  • Lymphocyte Activation
  • Recombinant Proteins / pharmacology
  • Stimulation, Chemical

Substances

  • HLA Antigens
  • HLA-C Antigens
  • HLA-C*70 antigen
  • Recombinant Proteins
  • Interferon-gamma